Showing 37,981 - 38,000 results of 129,890 for search '(( i e decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.50s Refine Results
  1. 37981

    Table 1_Emergency department utilization among youth in foster care: benefits of a patient-centered medical home.pdf by Nicholas Szoko (11260475)

    Published 2025
    “…The patient-centered medical home (PCMH) offers a potential model to reduce overutilization of healthcare resources. …”
  2. 37982
  3. 37983
  4. 37984
  5. 37985

    Expression levels of <i>th1</i> and <i>th2</i> mRNA at 3 dpf in <i>pink1</i> morphants untreated and treated with LGR. by Madhusmita Priyadarshini (490074)

    Published 2013
    “…A decrease in <i>th1</i> expression in the population 5,6,11 (*) in morphants (B) was observed as compared to the ctrl MO group (A). …”
  6. 37986

    Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction by Jun Luo (120285)

    Published 2025
    “…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
  7. 37987

    Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction by Jun Luo (120285)

    Published 2025
    “…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
  8. 37988

    Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction by Jun Luo (120285)

    Published 2025
    “…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
  9. 37989

    Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction by Jun Luo (120285)

    Published 2025
    “…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
  10. 37990

    Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction by Jun Luo (120285)

    Published 2025
    “…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
  11. 37991
  12. 37992

    Detailed Analysis of Sequence Changes Occurring during <em>vlsE</em> Antigenic Variation in the Mouse Model of <em>Borrelia burgdorferi</em> Infection by Loïc Coutte (124900)

    Published 2009
    “…Sequence changes as small as one base pair were common. Fifteen percent of recovered <em>vlsE</em> variants contained “template-independent” sequence changes, which clustered in the variable regions of <em>vlsE</em>. …”
  13. 37993
  14. 37994

    Table_3_Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations.DOCX by Euphemia Y. Leung (595077)

    Published 2018
    “…We have derived and grown a series of four human breast cancer cell lines under 5% oxygen, and have compared their properties to those of established breast cancer lines growing under ambient oxygen.…”
  15. 37995

    Table_2_Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations.DOCX by Euphemia Y. Leung (595077)

    Published 2018
    “…We have derived and grown a series of four human breast cancer cell lines under 5% oxygen, and have compared their properties to those of established breast cancer lines growing under ambient oxygen.…”
  16. 37996
  17. 37997
  18. 37998
  19. 37999

    Table_1_Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.DOCX by Yue Qiao (4708423)

    Published 2023
    “…It is reported that lecanemab was beneficial to stabilize or slow down the decrease in CDR-SB (WMD: −0.45; 95% CI: −0.64, −0.25; p < 0.00001), ADCOMS (WMD: −0.05; 95% CI: −0.07, −0.03; p < 0.00001), ADAS-cog (WMD: −1.11; 95% CI: −1.64, −0.57; p < 0.0001), amyloid PET SUVr (WMD: −0.15; 95% CI: −0.48, 0.19; p = 0.38), amyloid burden on PET (WMD:−35.44; 95% CI: −65.22,−5.67; p = 0.02), adverse events (subjects with any TEAE) (OR: 0.73; 95% CI: 0.25, 2.15; p = 0.57), ARIA-E (OR:8.95; 95% CI: 5.36, 14.95; p < 0.00001), and ARIA-H (OR:2.00; 95% CI: 1.53, 2.62; p < 0.00001) in early AD patients.…”
  20. 38000